arrow
A

Antonio J. Carcas

clinical pharmacology department
H指数:31
被引数:3,609

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Limitations of VKORC1 rs9934438 as a Surrogate Marker for Vitamin K Antagonist Dose Adjustment

<i>VKORC1</i> rs9934438作为维生素K拮抗剂剂量调整替代标记物的局限性

2026-10-020
PRE
Pre-emptive CYP2C19 genotyping and voriconazole exposure in pediatric hematology patients at risk of aspergillosis: an exploratory randomized pilot study with a cost-consequence analysis

CYP2C19基因分型预判和伏立康唑暴露在患有曲霉菌病风险的小儿血液科患者中的探索性随机试点研究:一项成本后果分析

2026-07-230
OAAI
Integrating pharmacogenetic and clinical factors to predict the C0/D/W-based tacrolimus phenotype in kidney transplantation

整合药代遗传和临床因素以预测肾移植中基于C0/D/W的他克莫司表型

2026-05-150
OA
Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) – final report
2026-02-060
OAAI
Disproportionality Analysis of the Five Most Widespread Neurological Effects of COVID-19 Vaccines from 2021 to 2023: Insights from Eudra Vigilance

2021年至2023年COVID-19疫苗五种最常见神经系统效应的不成比例性分析:来自Eudra Vigilance的见解

2025-04-270
OA
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe
2024-01-018
PRE
Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit
2023-04-034
OAAI
No changes in hemostasis after COVID-19-heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study
2023-01-010
OAAI
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial
2022-08-2015
OA
Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study
2022-08-014
OAAI
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR
2022-06-1327
OA
Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial
2022-02-216
OAAI
A Case-Control of Patients with COVID-19 to Explore the Association of Previous Hospitalisation Use of Medication on the Mortality of COVID-19 Disease: A Propensity Score Matching Analysis
2022-01-088
OAAI
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
2021-09-0126
OAAI